NASDAQ:KLRS | Income Statement | Kalaris Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$9.02M$12.39M-$12.39M$871,000.00-$11.52M-$0.48-$0.4823,797,30623,797,306
2026-03-31$7.57M$11.83M-$11.83M$977,000.00-$10.86M-$0.46-$0.4623,723,61823,723,618
2025-12-31$7.16M$10.8M-$10.8M$803,000.00-$10M-$0.44-$0.441,395,4481,395,448
2025-09-30$9.13M$12.74M-$12.74M$847,000.00-$11.89M-$0.64-$0.6418,701,70818,701,708
2025-06-30$8.44M$12.26M-$12.26M$906,000.00-$11.35M-$0.61-$0.6118,701,28618,701,286
2025-03-31$6.03M$10.35M-$10.35M$158,000.00-$10.2M-$2.52-$2.524,053,1404,053,140
2024-12-31$3.85M$7.13M-$7.13M-$14.89M-$22.03M-$16.33-$16.335,6705,670
2024-09-30$36.02M$37.85M-$37.85M-$235,000.00$0.00-$38.08M-$28.16-$28.161,352,2651,352,265
2024-06-30$3.21M$4.19M-$4.19M-$1.46M$0.00-$5.65M-$4.26-$4.261,325,7061,325,706
2024-03-31$1.96M$2.56M-$2.56M-$844,000.00$0.00-$3.41M-$2.60-$2.601,312,5521,312,552
2023-12-31$33.37M$62.41M-$62.41M-$59.82M-$126,000.00-$59.7M-$40.79-$40.79-96,159,096-96,159,096
2023-09-30$34.16M$46.96M-$46.96M-$44.27M$0.00-$44.27M-$0.39-$0.39113,894,188113,894,188
2023-06-30$34.82M$47.3M-$47.3M-$45.27M$0.00-$45.27M-$0.48-$0.4894,625,83794,625,837
2023-03-31$30.72M$43.23M-$43.23M$0.00-$41.18M-$0.44-$0.4493,303,67293,303,672
2022-12-31$28.42M$40.43M-$40.43M-$38.55M-$415,000.00-$38.14M-$0.37-$0.375,441,6375,441,637
2022-09-30$30M$42.95M-$42.95M-$42.07M$0.00-$42.07M-$0.50-$0.5084,948,83784,948,837
2022-06-30$31.38M$44.62M-$44.62M-$44.49M$150,000.00-$44.64M-$0.69-$0.6964,467,48364,467,483
2022-03-31$29.07M$43.19M-$43.19M-$43.86M$0.00-$43.86M-$0.69-$0.6963,993,05363,993,053
2021-12-31$41.6M$55.8M-$55.8M-$56.93M-$57.94M-$0.92-$0.92193,228193,228
2021-09-30$33.06M$45.5M-$45.5M-$45.51M-$45.51M-$0.72-$0.7262,962,43462,962,434
2021-06-30$25.68M$37.66M-$37.66M-$37.59M-$37.59M-$0.60-$0.6062,344,71862,344,718
2021-03-31$20.39M$30.86M-$30.86M$0.00-$30.92M62,193,734
2020-12-31$16.76M$25.42M-$25.42M-$25.2M11,702,390
2020-09-30$17.18M$23.9M-$23.9M-$23.61M40,465,705
2020-06-30$8.89M$12.15M-$12.15M-$11.63M2,625,648
2020-03-31$6.84M$9.84M-$9.84M-$9.34M2,215,958
2019-12-31$0.00$6.69M$9.51M-$9.51M-$8.74M181,479
2019-09-30$5.66M$8.48M-$8.48M-$7.27M1,463,421
2019-06-30$2.76M$5.95M-$5.95M-$5.3M1,050,190
2019-03-31-$2.52M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$30.75M$46.15M-$46.15M$2.71M-$43.44M$0.00-$43.44M-$2.85-$2.8515,267,81715,267,817
2024-12-31$45.04M$51.73M-$51.73M-$17.44M-$69.17M$0.00-$69.17M-$51.77-$51.771,335,9251,335,925
2023-12-31$133.07M$199.9M-$199.9M-$190.54M-$126,000.00-$190.42M-$42.09-$42.094,524,2264,524,226
2022-12-31$118.87M$171.2M-$171.2M-$168.98M-$265,000.00-$168.71M-$2.20-$2.2076,654,85676,654,856
2021-12-31$120.74M$169.82M-$169.82M-$170.96M$1.01M-$171.96M-$2.74-$2.7462,782,12662,782,126
2020-12-31$49.66M$71.31M-$71.31M-$69.78M-$69.78M26,897,390
2019-12-31$165,000.00$16.25M$26.87M-$26.7M-$23.84M-$23.84M1,285,933